Trial Profile
A Double-Blind, Placebo-Controlled Study of Circadin™ for Non-24 Hour Sleep-Wake Disorder in Totally Blind Subjects
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Melatonin (Primary)
- Indications Circadian rhythm sleep disorders
- Focus Therapeutic Use
- Sponsors NEURIM Pharmaceuticals
- 05 Dec 2014 New trial record